FARMACIA Y SALUD
Doktorego eskola
University of Copenhagen
Copenhague, DinamarcaUniversity of Copenhagen-ko ikertzaileekin lankidetzan egindako argitalpenak (6)
2024
-
Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)
Alimentary Pharmacology and Therapeutics, Vol. 59, Núm. 10, pp. 1248-1259
2023
-
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2
British Journal of Cancer, Vol. 128, Núm. 12, pp. 2283-2294
2021
-
Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer
Cancer Epidemiology Biomarkers and Prevention, Vol. 30, Núm. 9, pp. 1669-1680
2017
-
Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci
Oncotarget, Vol. 8, Núm. 39, pp. 64670-64684
2015
-
Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer
Clinical Cancer Research, Vol. 21, Núm. 3, pp. 652-657
-
Identification of six new susceptibility loci for invasive epithelial ovarian cancer
Nature Genetics, Vol. 47, Núm. 2, pp. 164-171